{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T13:15:20Z","timestamp":1723295720745},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,11,5]],"date-time":"2010-11-05T00:00:00Z","timestamp":1288915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,11,5]],"date-time":"2010-11-05T00:00:00Z","timestamp":1288915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1038\/cgt.2010.69","type":"journal-article","created":{"date-parts":[[2010,11,5]],"date-time":"2010-11-05T11:17:50Z","timestamp":1288955870000},"page":"189-195","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Combining radiation therapy with interstitial radiation-inducible TNF-\u03b1 expression for locoregional cancer treatment"],"prefix":"10.1038","volume":"18","author":[{"given":"M","family":"Jung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Dimtchev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Velena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Dritschilo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,5]]},"reference":[{"key":"BFcgt201069_CR1","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/0360-3016(96)00214-3","volume":"35","author":"M Dattoli","year":"1996","unstructured":"Dattoli M, Wallner K, Sorace R, Koval J, Cash J, Acosta R et al. 103Pd Brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma. Int J Radiat Oncol Biol Phys 1996; 35: 875\u2013879.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFcgt201069_CR2","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S1053-4296(05)80121-3","volume":"3","author":"J Blasko","year":"1993","unstructured":"Blasko J, Grimm P, Radge H . Brachytherapy and organ preservation in the management of carcinoma of the prostate. Semin Radiat Oncol 1993; 3: 240\u2013249.","journal-title":"Semin Radiat Oncol"},{"key":"BFcgt201069_CR3","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/(SICI)1097-0142(19980901)83:5<989::AID-CNCR26>3.0.CO;2-Q","volume":"83","author":"H Radge","year":"1998","unstructured":"Radge H, Elgamal A, Snow P, Brandt J, Bartolucci A, Nadir B et al. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinoma. Cancer 1998; 83: 989\u20131001.","journal-title":"Cancer"},{"key":"BFcgt201069_CR4","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1200\/JCO.1999.17.4.1155","volume":"17","author":"American Society for Therapeutic Radiology and Oncology Consensus Panel","year":"1999","unstructured":"American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus Statements on Radiation Therapy of Prostate Cancer: Guidelines for Prostate Re-Biopsy After Radiation and for Radiation Therapy with Rising Prostate-specific Antigen Levels after Radical Prostatectomy. J Clin Oncol 1999; 17: 1155\u20131163.","journal-title":"J Clin Oncol"},{"key":"BFcgt201069_CR5","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1002\/1097-0142(19950501)75:9<2383::AID-CNCR2820750931>3.0.CO;2-Z","volume":"75","author":"F Critz","year":"1995","unstructured":"Critz F, Tarlton R, Holladay D . Prostate specific antigen-monitored combination radiotherapy for patients with prostate cancer. Cancer 1995; 75: 2382\u20132391.","journal-title":"Cancer"},{"key":"BFcgt201069_CR6","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1200\/JCO.1996.14.11.2889","volume":"14","author":"PW McLaughlin","year":"1996","unstructured":"McLaughlin PW, Sandler H, Jiroutek M . Prostate-specific antigen following prostate radiotherapy: how low can you go? J Clin Oncol 1996; 14: 2889\u20132892.","journal-title":"J Clin Oncol"},{"key":"BFcgt201069_CR7","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1200\/JCO.1996.14.11.2893","volume":"14","author":"F Critz","year":"1996","unstructured":"Critz F, Levinson AK, Williams WH, Holladay D . Prostate-specific Antigen Nadir: the optimum level after irradiation for prostate cancer. J Clin Oncol 1996; 14: 2893\u20132900.","journal-title":"J Clin Oncol"},{"key":"BFcgt201069_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0360-3016(94)90006-X","volume":"30","author":"G Hanks","year":"1994","unstructured":"Hanks G, Perez C, Kozar M, Asbell S, Pilepich M, Pajak T . PSA confirmation of cure at 10 years of T1B, T2, N0, M0 prostate cancer patients treated in RTOG protocol 7706 with external beam irradiation. Int J Radiat Oncol Biol Phys 1994; 30: 289\u2013292.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFcgt201069_CR9","first-page":"803","volume":"9","author":"R Stock","year":"1995","unstructured":"Stock R . Locoregional therapies for early-stage prostate cancer. Oncology 1995; 9: 803\u2013811.","journal-title":"Oncology"},{"key":"BFcgt201069_CR10","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/(SICI)1097-0142(19970801)80:3<442::AID-CNCR12>3.0.CO;2-X","volume":"80","author":"H Radge","year":"1997","unstructured":"Radge H, Blasko J, Grimm P, Kenny G, Sylvester J, Hoak D et al. Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma. Cancer 1997; 80: 442\u2013453.","journal-title":"Cancer"},{"key":"BFcgt201069_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0360-3016(98)00097-2","volume":"41","author":"T Mate","year":"1998","unstructured":"Mate T, Gottesman J, Hatton J, Gribble M, Van Hollebeke L . High dose-rate after loading 192Iridium prostate brachytherapy: feasibility report: Int. J Radiat Oncol Biol Phys 1998; 41: 525\u2013533.","journal-title":"J Radiat Oncol Biol Phys"},{"key":"BFcgt201069_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/0360-3016(92)91075-X","volume":"24","author":"RR Weichselbaum","year":"1992","unstructured":"Weichselbaum RR, Hallahan DE, Sukhatme VP, Kufe DW . Gene therapy targeted by ionizing radiation. Int. J Radiat Oncol Biol Phys 1992; 24: 565\u2013567.","journal-title":"J Radiat Oncol Biol Phys"},{"key":"BFcgt201069_CR13","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/cgt.2009.32","volume":"16","author":"SR Murugesan","year":"2009","unstructured":"Murugesan SR, King CR, Osborn R, Fairweather WR, O'Reilly EM, Thornton MO et al. Combination of human tumor necrosis factor-alpha (hTNF-a) gene delivery with gemcitabine is effective in models of pancreatic cancer. Cancer Gene Ther 2009; 16: 841\u2013847.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201069_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/cgt.2009.37","volume":"16","author":"RR Weichselbaum","year":"2009","unstructured":"Weichselbaum RR, Kufe DW . Translation of the radio- and chemo-inducible TNFerade vector to the treatment of human cancers. Rev Cancer Gene Ther 2009; 16: 609\u2013619.","journal-title":"Rev Cancer Gene Ther"},{"issue":"12","key":"BFcgt201069_CR15","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.bcp.2010.06.039","volume":"80","author":"Amit Deorukhkar","year":"2010","unstructured":"Deorukhkar A, Krishnan S . Targeting inflammatory pathways for tumor radiosensitization. Biochem Pharmacol 2010. Jun 30. (E-pub ahead of print), doi:10.1016\/j.bcp.2010.06.039.","journal-title":"Biochemical Pharmacology"},{"key":"BFcgt201069_CR16","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1158\/0008-5472.CAN-09-2995","volume":"70","author":"Y Meng","year":"2010","unstructured":"Meng Y, Beckett MA, Liang H, Mauceri HJ, van Rooijen N, Cohen KS et al. Blockade of tumor necrosis factor alpha signaling in tumor-associated macrophages as a radiosensitizing strategy. Cancer Res 2010; 70: 1534\u20131543.","journal-title":"Cancer Res"},{"key":"BFcgt201069_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/cgt.2008.86","volume":"16","author":"HJ Mauceri","year":"2009","unstructured":"Mauceri HJ, Beckett MA, Liang H, Sutton HG, Pitroda S, Galka E et al. Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapy. Cancer Gene Ther 2009; 16: 373\u2013381.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201069_CR18","first-page":"1498","volume":"56","author":"A Kondratyev","year":"1996","unstructured":"Kondratyev A, Chung K-N, Jung M . Identification characterization of radiation-inducible glyclosylated human early response gene. Cancer Res 1996; 56: 1498\u20131502.","journal-title":"Cancer Res"},{"key":"BFcgt201069_CR19","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1126\/science.281.5379.998","volume":"281","author":"MX Wu","year":"1998","unstructured":"Wu MX, Ao Z, Prasad KV, Wu R, Schlossman SF . IEX-1L, an apoptosis inhibitor involved in NF-\u03baB-mediated cell survival. Science 1998; 281: 998\u20131001.","journal-title":"Science"},{"key":"BFcgt201069_CR20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/cdd.2008.184","volume":"16","author":"L Shen","year":"2009","unstructured":"Shen L, Zhi L, Hu W, Wu MX . IEX-1 targets mitochondrial F1Fo-ATPase inhibitor for degradation. Cell Death Differ 2009; 16: 603\u2013612.","journal-title":"Cell Death Differ"},{"key":"BFcgt201069_CR21","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/sj.onc.1210728","volume":"27","author":"SS Muerkoster","year":"2008","unstructured":"Muerkoster SS, Rausch AV, Isberner A, Minkenberg J, Blaszczuk E, Witt M et al. The apoptosis-inducing effect of gastrin on colorectal cancer cells relates to an increased IEX-1 expression mediating NF-kB inhibition. Oncogene 2008; 27: 1122\u20131134.","journal-title":"Oncogene"},{"key":"BFcgt201069_CR22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1158\/1535-7163.655.3.6","volume":"3","author":"M Jung","year":"2004","unstructured":"Jung M, Zhang Y, Dimtohev A, Subramanian M, Suthanthiran K, Dritschilo A . Interstitial gene delivery in human xenograft prostate tumors using titanium metal seeds. Mol Cancer Ther 2004; 3: 655\u2013659.","journal-title":"Mol Cancer Ther"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt201069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201069","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T03:47:49Z","timestamp":1685850469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt201069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,5]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["BFcgt201069"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2010.69","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,5]]},"assertion":[{"value":"1 April 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}